Du, S., Shi, H., Xiong, L., Wang, P., & Shi, Y. (2022). Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy. Frontiers in endocrinology (Lausanne), 13, 1011669. https://doi.org/10.3389/fendo.2022.1011669
Chicago Style (17th ed.) CitationDu, Shuqin, Hanqiang Shi, Lie Xiong, Ping Wang, and Yanbo Shi. "Canagliflozin Mitigates Ferroptosis and Improves Myocardial Oxidative Stress in Mice with Diabetic Cardiomyopathy." Frontiers in Endocrinology (Lausanne) 13 (2022): 1011669. https://doi.org/10.3389/fendo.2022.1011669.
MLA (9th ed.) CitationDu, Shuqin, et al. "Canagliflozin Mitigates Ferroptosis and Improves Myocardial Oxidative Stress in Mice with Diabetic Cardiomyopathy." Frontiers in Endocrinology (Lausanne), vol. 13, 2022, p. 1011669, https://doi.org/10.3389/fendo.2022.1011669.